Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphotransferases (Alcohol Group Acceptor) | 8 | 2019 | 16 | 2.060 |
Why?
|
| Leukemia, Myeloid, Acute | 8 | 2020 | 200 | 1.170 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2016 | 24 | 0.710 |
Why?
|
| Lysine | 1 | 2019 | 23 | 0.700 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 19 | 0.700 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 31 | 0.690 |
Why?
|
| Carrier Proteins | 2 | 2019 | 136 | 0.660 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2016 | 2 | 0.570 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2018 | 34 | 0.490 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 148 | 0.460 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2016 | 85 | 0.380 |
Why?
|
| Leukemia, Myeloid | 2 | 2009 | 24 | 0.360 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 322 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 3 | 2017 | 99 | 0.350 |
Why?
|
| Osteopontin | 1 | 2009 | 10 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2005 | 15 | 0.330 |
Why?
|
| Mice | 13 | 2020 | 2472 | 0.330 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2009 | 100 | 0.330 |
Why?
|
| Signal Transduction | 7 | 2016 | 682 | 0.310 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 725 | 0.300 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 165 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2018 | 114 | 0.270 |
Why?
|
| Loss of Heterozygosity | 2 | 2002 | 20 | 0.260 |
Why?
|
| Cell Survival | 5 | 2016 | 285 | 0.250 |
Why?
|
| Sphingosine | 4 | 2018 | 13 | 0.240 |
Why?
|
| Mice, Inbred NOD | 4 | 2017 | 25 | 0.240 |
Why?
|
| Protein Phosphatase 2 | 2 | 2016 | 5 | 0.230 |
Why?
|
| Humans | 25 | 2020 | 31981 | 0.230 |
Why?
|
| Animals | 14 | 2020 | 7463 | 0.230 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 761 | 0.220 |
Why?
|
| Lysophospholipids | 3 | 2018 | 24 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 607 | 0.210 |
Why?
|
| Phosphoserine | 3 | 2013 | 8 | 0.200 |
Why?
|
| Cullin Proteins | 2 | 2019 | 6 | 0.190 |
Why?
|
| Amino Acid Motifs | 2 | 2019 | 24 | 0.190 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 137 | 0.180 |
Why?
|
| Cell Membrane | 2 | 2018 | 96 | 0.180 |
Why?
|
| Ubiquitination | 1 | 2019 | 16 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 261 | 0.170 |
Why?
|
| Caspases | 2 | 2016 | 37 | 0.170 |
Why?
|
| Cell Death | 2 | 2016 | 77 | 0.170 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Wrist | 1 | 2019 | 48 | 0.160 |
Why?
|
| Wrist Joint | 1 | 2019 | 60 | 0.160 |
Why?
|
| Wrist Injuries | 1 | 2019 | 43 | 0.160 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 121 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2016 | 488 | 0.160 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 8 | 0.150 |
Why?
|
| Head Injuries, Penetrating | 1 | 2017 | 3 | 0.150 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2017 | 1 | 0.150 |
Why?
|
| Benzothiazoles | 1 | 2017 | 2 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2017 | 4 | 0.150 |
Why?
|
| Amino Alcohols | 1 | 2016 | 1 | 0.140 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2016 | 6 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 34 | 0.140 |
Why?
|
| Quinolines | 1 | 2016 | 21 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2018 | 156 | 0.140 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 17 | 0.140 |
Why?
|
| Pain | 1 | 2019 | 288 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2018 | 354 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2016 | 108 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2018 | 598 | 0.130 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2015 | 1 | 0.130 |
Why?
|
| Algorithms | 1 | 2019 | 496 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 51 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 53 | 0.130 |
Why?
|
| Female | 8 | 2019 | 19920 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 71 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 44 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 168 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 79 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 34 | 0.110 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2013 | 2 | 0.110 |
Why?
|
| Apoptosis | 4 | 2018 | 352 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 5 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 244 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2013 | 228 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 61 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1324 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2013 | 468 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 208 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 918 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 311 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2016 | 135 | 0.100 |
Why?
|
| 14-3-3 Proteins | 2 | 2009 | 4 | 0.100 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 20 | 0.100 |
Why?
|
| Cytokines | 1 | 2013 | 255 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 35 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 409 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2008 | 50 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 435 | 0.090 |
Why?
|
| Brain | 1 | 2017 | 950 | 0.090 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2009 | 2 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2009 | 507 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2009 | 29 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 41 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 77 | 0.090 |
Why?
|
| Neurons | 1 | 2013 | 409 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2009 | 1 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 114 | 0.080 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 4 | 0.070 |
Why?
|
| F-Box Proteins | 1 | 2005 | 4 | 0.070 |
Why?
|
| Prognosis | 1 | 2009 | 1505 | 0.060 |
Why?
|
| Male | 5 | 2019 | 19161 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2013 | 442 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 261 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2014 | 71 | 0.060 |
Why?
|
| Mutation | 3 | 2015 | 488 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 8 | 0.050 |
Why?
|
| G2 Phase | 2 | 2017 | 17 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 8 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 137 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 49 | 0.050 |
Why?
|
| Cell Division | 2 | 2017 | 95 | 0.050 |
Why?
|
| Proteins | 1 | 2002 | 145 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 130 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2020 | 4 | 0.050 |
Why?
|
| Biological Availability | 1 | 2020 | 21 | 0.050 |
Why?
|
| Dipeptides | 1 | 2020 | 9 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2013 | 833 | 0.050 |
Why?
|
| Indoles | 1 | 2020 | 56 | 0.050 |
Why?
|
| Aged | 2 | 2010 | 10332 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 834 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 391 | 0.040 |
Why?
|
| Forensic Medicine | 1 | 2017 | 14 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 52 | 0.040 |
Why?
|
| Ceramides | 1 | 2016 | 10 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 10 | 0.030 |
Why?
|
| Niacinamide | 1 | 2016 | 8 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 74 | 0.030 |
Why?
|
| Adult | 1 | 2009 | 9340 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2015 | 4 | 0.030 |
Why?
|
| Daunorubicin | 1 | 2015 | 27 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 26 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 25 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2015 | 1 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cytarabine | 1 | 2015 | 55 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2015 | 33 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 122 | 0.030 |
Why?
|
| Middle Aged | 1 | 2009 | 11845 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 73 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 201 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 82 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 5 | 0.030 |
Why?
|
| Genes, myc | 1 | 2014 | 5 | 0.030 |
Why?
|
| Adamantane | 1 | 2014 | 3 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 15 | 0.030 |
Why?
|
| Histones | 1 | 2014 | 53 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 333 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 76 | 0.030 |
Why?
|
| Hydrazones | 1 | 2013 | 3 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2013 | 14 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 6 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2013 | 67 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 84 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2010 | 2 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 40 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mast Cells | 1 | 2009 | 11 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1596 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 50 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2008 | 23 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 70 | 0.020 |
Why?
|
| Hela Cells | 1 | 2008 | 78 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 99 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 48 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 227 | 0.020 |
Why?
|
| Serine | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 19 | 0.020 |
Why?
|
| G1 Phase | 1 | 2005 | 11 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 8 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2005 | 18 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 23 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 31 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 33 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 54 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 692 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 40 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 515 | 0.010 |
Why?
|